Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |